Another useful finding is that EX effectively treats obese subjects with T2DM on insulin, leading to weight loss and decrease in levels of HbA(1)c, systolic blood pressure, triglycerides and high-sensitivity C-reactive protein (CRP)[53]. Here, CRP is linked to type 2 diabetes mellitus.